BioCentury | Nov 13, 2020
Deals

Nov. 12 Quick Takes: MorphoSys, UCB bring in new tech via deals; plus Cevec-Roche, Bridge-BI, Affimed-Roivant, Insilico-J&J, TCR2-ElevateBio

...discovery deal with J&J Insilico Medicine Inc. entered into a multitarget drug discovery agreement with Janssen Pharmaceutica...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...will become CMO, a newly created position. Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd....
BioCentury | May 29, 2020
Product Development

Minerva’s schizophrenia miss casts doubt on approach to treating negative symptoms

...Behind roluperidone, Minerva’s pipeline includes seltorexant (MIN-202), an OX2R antagonist. The biotech and the Janssen Pharmaceutica...
BioCentury | Jan 24, 2020
Preclinical News

Jan. 23 Preclinical Quick Takes: Metastasis-associated cancer-associated fibroblast populations; plus NIH-TeneoBio and Basilea

...presentation at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO), Basilea Pharmaceutica Ltd....
...factor β BioCentury Staff TeneoBio Inc. Institut Curie Institut National de la Sante et de la Recherche Medicale (INSERM) NIH Basilea Pharmaceutica Ltd. Integrin...
BioCentury | Jan 2, 2020
Company News

Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention

...therapies, as well as regenerative medicine. Janssen declines option for Provention Crohn's disease candidate Janssen Pharmaceutica...
BioCentury | Nov 15, 2019
Product Development

Minerva on the verge in neuropsychiatry with two compounds close to verdict

...Minerva is leading development for insomnia, and co-developing the compound for depression with J&J’s Janssen Pharmaceutica...
BioCentury | Oct 11, 2019
Company News

Oct. 11 Company Quick Takes: FDA approves Lilly migraine drug; plus Clovis, Evotec-Celmatix, Avacta-ADC and Neumentum-J&J

...Pain company Neumentum Inc. licensed global rights to JNJ-10450232 and backup compounds from the Janssen Pharmaceutica...
BioCentury | Jun 3, 2019
Company News

June 3 Company Quick Takes: EU pharmas form consortium to predict late-stage success; plus Lilly/Atomwise, Gilead/HitGen, Emergent and more

...Learning Ledger Orchestration for Drug Discovery), includes 17 partners from across Europe with the Janssen Pharmaceutica...
BioCentury | May 2, 2019
Company News

Forge, Basilea to develop antibiotics against unexploited targets

...Forge and Basilea Pharmaceutica International Ltd. partnered to discover, develop and commercialize antibiotics against two undisclosed...
...royalties. Basilea Pharmaceutica International Ltd. is a subsidiary of Basilea Pharmaceutica Ltd. (SIX:BSLN). Shannon Lehnbeuter, Staff Writer Basilea Pharmaceutica Ltd. Forge...
BioCentury | Feb 12, 2019
Company News

Management tracks: Sanofi, Alexion, bluebird

...Eva-Maria Joed, who will become VP of finance and administration. Spota was CFO at Basilea Pharmaceutica...
Items per page:
1 - 10 of 706
BioCentury | Nov 13, 2020
Deals

Nov. 12 Quick Takes: MorphoSys, UCB bring in new tech via deals; plus Cevec-Roche, Bridge-BI, Affimed-Roivant, Insilico-J&J, TCR2-ElevateBio

...discovery deal with J&J Insilico Medicine Inc. entered into a multitarget drug discovery agreement with Janssen Pharmaceutica...
BioCentury | May 30, 2020
Management Tracks

Schneyer named Acadia CBO; plus Hansa, MaaT, iOnctura, First Light, Oligomerix, Galecto and Hyloris

...will become CMO, a newly created position. Before joining the autoimmune company, he served Basilea Pharmaceutica Ltd....
BioCentury | May 29, 2020
Product Development

Minerva’s schizophrenia miss casts doubt on approach to treating negative symptoms

...Behind roluperidone, Minerva’s pipeline includes seltorexant (MIN-202), an OX2R antagonist. The biotech and the Janssen Pharmaceutica...
BioCentury | Jan 24, 2020
Preclinical News

Jan. 23 Preclinical Quick Takes: Metastasis-associated cancer-associated fibroblast populations; plus NIH-TeneoBio and Basilea

...presentation at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO), Basilea Pharmaceutica Ltd....
...factor β BioCentury Staff TeneoBio Inc. Institut Curie Institut National de la Sante et de la Recherche Medicale (INSERM) NIH Basilea Pharmaceutica Ltd. Integrin...
BioCentury | Jan 2, 2020
Company News

Jan. 3 Company Quick Takes: Illumina, PacBio call off deal; plus Innovax, Innate, J&J-Pulmatrix, Intrexon, Janssen-Provention

...therapies, as well as regenerative medicine. Janssen declines option for Provention Crohn's disease candidate Janssen Pharmaceutica...
BioCentury | Nov 15, 2019
Product Development

Minerva on the verge in neuropsychiatry with two compounds close to verdict

...Minerva is leading development for insomnia, and co-developing the compound for depression with J&J’s Janssen Pharmaceutica...
BioCentury | Oct 11, 2019
Company News

Oct. 11 Company Quick Takes: FDA approves Lilly migraine drug; plus Clovis, Evotec-Celmatix, Avacta-ADC and Neumentum-J&J

...Pain company Neumentum Inc. licensed global rights to JNJ-10450232 and backup compounds from the Janssen Pharmaceutica...
BioCentury | Jun 3, 2019
Company News

June 3 Company Quick Takes: EU pharmas form consortium to predict late-stage success; plus Lilly/Atomwise, Gilead/HitGen, Emergent and more

...Learning Ledger Orchestration for Drug Discovery), includes 17 partners from across Europe with the Janssen Pharmaceutica...
BioCentury | May 2, 2019
Company News

Forge, Basilea to develop antibiotics against unexploited targets

...Forge and Basilea Pharmaceutica International Ltd. partnered to discover, develop and commercialize antibiotics against two undisclosed...
...royalties. Basilea Pharmaceutica International Ltd. is a subsidiary of Basilea Pharmaceutica Ltd. (SIX:BSLN). Shannon Lehnbeuter, Staff Writer Basilea Pharmaceutica Ltd. Forge...
BioCentury | Feb 12, 2019
Company News

Management tracks: Sanofi, Alexion, bluebird

...Eva-Maria Joed, who will become VP of finance and administration. Spota was CFO at Basilea Pharmaceutica...
Items per page:
1 - 10 of 706